Paul M. Kaye

12.3k total citations · 1 hit paper
195 papers, 9.4k citations indexed

About

Paul M. Kaye is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Epidemiology. According to data from OpenAlex, Paul M. Kaye has authored 195 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Public Health, Environmental and Occupational Health, 88 papers in Immunology and 63 papers in Epidemiology. Recurrent topics in Paul M. Kaye's work include Research on Leishmaniasis Studies (133 papers), Trypanosoma species research and implications (55 papers) and Immune Cell Function and Interaction (41 papers). Paul M. Kaye is often cited by papers focused on Research on Leishmaniasis Studies (133 papers), Trypanosoma species research and implications (55 papers) and Immune Cell Function and Interaction (41 papers). Paul M. Kaye collaborates with scholars based in United Kingdom, United States and Switzerland. Paul M. Kaye's co-authors include Christian Engwerda, Phillip Scott, Simona Stäger, Asher Maroof, Manabu Ato, Sara E. J. Cotterell, Lynette Beattie, Alun C. Kirby, Mattias Svensson and Deborah F. Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Paul M. Kaye

193 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leishmaniasis: complexity at the host–pathogen interface

2011 667 citations Paul M. Kaye et al. profile →

Peers

Countries citing papers authored by Paul M. Kaye

Since Specialization

Citations

This map shows the geographic impact of Paul M. Kaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Kaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Kaye more than expected).

Fields of papers citing papers by Paul M. Kaye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Kaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Kaye. The network helps show where Paul M. Kaye may publish in the future.

Co-authorship network of co-authors of Paul M. Kaye

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Kaye. A scholar is included among the top collaborators of Paul M. Kaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Kaye. Paul M. Kaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IL-32–producing CD8+ memory T cells define immunoregulatory niches in human cutaneous leishmaniasis 2025 ·Journal of Clinical Investigation ·(unknown), (unknown), (unknown), (unknown), Luiza Campos Reis, (unknown), José Ângelo Lauletta Lindoso, Sally James, (unknown), Dave Boucher, Mitali Chatterjee, Hiro Goto, Shalindra Ranasinghe, Paul M. Kaye	1
2	Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in Sarcoidosis 2024 ·Lung ·Simon Fraser, Susannah Thackray-Nocera, Caroline Wright, Rachel Flockton, Sally James, Michael G. Crooks, Paul M. Kaye, Simon P. Hart	1
3	Development of a Core Outcome Measure Instrument; "LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis 2024 ·PLoS neglected tropical diseases ·Shalindra Ranasinghe, (unknown), (unknown), Charles Lacey, (unknown), (unknown), (unknown), Hiro Goto, Mitali Chatterjee, José Ângelo Lauletta Lindoso, (unknown), (unknown), Renu Wickremasinghe, Nilay Kanti Das, Paul M. Kaye, Alison Layton	1
4	Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19 2023 ·Clinical & Experimental Immunology ·(unknown), Helen Ashwin, (unknown), (unknown), Joaquim Majó Fernández, Andrew Filby, Andrew J. Fisher, Paul M. Kaye, Dimitris Lagos	6
5	Immune dysregulation and inflammation causing hypopigmentation in post kala-azar dermal leishmaniasis: partners in crime? 2023 ·Trends in Parasitology ·(unknown), (unknown), (unknown), Paul M. Kaye, Mitali Chatterjee	8
6	Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates 2022 ·PLoS neglected tropical diseases ·Sakshi Mohan, Paul Revill, Stefano Malvolti, (unknown), Mark Sculpher, Paul M. Kaye	23
7	Tissue Specific Dual RNA-Seq Defines Host–Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum 2022 ·Microbiology Spectrum ·Sarah Forrester, (unknown), (unknown), (unknown), Milton Ozório Moraes, Paul M. Kaye, Jeremy C. Mottram, Ana Paula C. A. Lima	9
8	Characterization of a new Leishmania major strain for use in a controlled human infection model 2021 ·Nature Communications ·Helen Ashwin, Jovana Sádlová, Barbora Vojtková, (unknown), Patrick Lypaczewski, Eli Schwartz, (unknown), Katrien Van Bocxlaer, (unknown), (unknown), (unknown), Greg Matlashewski, Alison Layton, Charles Lacey, Charles L. Jaffe, Petr Volf, Paul M. Kaye	34
9	Human leishmaniasis vaccines: Use cases, target population and potential global demand 2021 ·PLoS neglected tropical diseases ·Stefano Malvolti, (unknown), Carsten Mantel, Epke A. Le Rutte, Paul M. Kaye	26
10	High-speed, three-dimensional imaging reveals chemotactic behaviour specific to human-infective Leishmania parasites 2021 ·eLife ·(unknown), Mohamed Osman, (unknown), Paul M. Kaye, Pegine B. Walrad, Laurence G. Wilson	12
11	The potential impact of human visceral leishmaniasis vaccines on population incidence 2020 ·PLoS neglected tropical diseases ·Epke A. Le Rutte, Luc E. Coffeng, Stefano Malvolti, Paul M. Kaye, Sake J. de Vlas	16
12	Malat1 Suppresses Immunity to Infection through Promoting Expression of Maf and IL-10 in Th Cells 2020 ·The Journal of Immunology ·James P. Hewitson, (unknown), Kylie R. James, (unknown), (unknown), Audrey Romano, Najmeeyah Brown, Sarah A. Teichmann, Paul M. Kaye, Dimitris Lagos	46
13	miR‐132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity 2019 ·EMBO Reports ·James P. Hewitson, Kunal Shah, Najmeeyah Brown, (unknown), (unknown), Katherine Newling, Tyson V. Sharp, Paul M. Kaye, Dimitris Lagos	13
14	Skin parasite landscape determines host infectiousness in visceral leishmaniasis 2017 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Najmeeyah Brown, Audrey Romano, Jane E. Dalton, (unknown), Jon W. Pitchford, Paul M. Kaye	46
15	Alveolar macrophages transport pathogens to lung draining lymph nodes 2008 ·Immunology ·Alun C. Kirby, (unknown), Paul M. Kaye	1
16	Chronic Leishmania donovani Infection Promotes Bystander CD8 ⁺ -T-Cell Expansion and Heterologous Immunity 2005 ·Infection and Immunity ·(unknown), Stéphanie L. Sanos, Sara R. Prickett, Ashraful Haque, Paul M. Kaye	17
17	Leishmania -Induced Inhibition of Macrophage Antigen Presentation Analyzed at the Single-Cell Level 2003 ·The Journal of Immunology ·Courtney L. Meier, Mattias Svensson, Paul M. Kaye	40
18	Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection 1998 ·European Journal of Immunology ·(unknown), Christian Engwerda, Paul M. Kaye	12
19	Dendritic cells, but not macrophages, produce IL-12 immediately followingLeishmania donovani infection 1998 ·European Journal of Immunology ·(unknown), Christian Engwerda, Paul M. Kaye	229
20	Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation. 1994 ·PubMed ·Debbie A. Smith, Q. D. Bickle, Paul M. Kaye	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact